SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-034068
Filing Date
2022-06-03
Accepted
2022-06-03 16:33:35
Documents
1
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4540
  Complete submission text file 0001209191-22-034068.txt   6154
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Issuer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HISTOGEN INC. 10655 SORRENTO VALLEY ROAD, SUITE 200 SAN DIEGO CA 92121
Business Address
Crean David Hugh (Reporting) CIK: 0001810100 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36003 | Film No.: 22995054